Literature DB >> 2645551

Glaucoma in patients with ocular cicatricial pemphigoid.

J Tauber1, S Melamed, C S Foster.   

Abstract

This retrospective review of 111 patients with ocular cicatricial pemphigoid (CP) identifies 29 patients (26%) with glaucoma. Twenty-seven of these patients had a history of glaucoma for a mean of 11.3 years before the diagnosis of CP was made. Most had advanced glaucoma, with a long history of medication use, optic nerve damage, and visual field loss. Patients with CP and glaucoma were more likely to manifest continued high-grade conjunctival inflammation than those with CP alone despite treatment for CP (P less than 0.05). Possible mechanisms including genetic susceptibility to both diseases, drug-induced conjunctival cicatrization, and CP-induced alterations in aqueous outflow are discussed. Physicians who care for patients with CP should remain mindful of the possible coexistence or development of glaucoma in this group of patients. Patients with glaucoma and chronic conjunctivitis of uncertain etiology should be referred for evaluation by physicians experienced in the detection and management of CP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2645551     DOI: 10.1016/s0161-6420(89)32942-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  10 in total

Review 1.  Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.

Authors:  J Javier Servat; C Robert Bernardino
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

2.  Intraocular pressure control with Ahmed glaucoma drainage device in patients with cicatricial ocular surface disease-associated or aniridia-related glaucoma.

Authors:  Radwan Almousa; Damian B Lake
Journal:  Int Ophthalmol       Date:  2013-10-18       Impact factor: 2.031

3.  Cryotherapy for trichiasis in ocular cicatricial pemphigoid.

Authors:  M J Elder; W Bernauer
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

4.  Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells.

Authors:  Kazuhide Kawase; Wenzhong Lin; Yumiko Aoyama; Tetsuya Yamamoto; Masamitsu Shimazawa; Hideaki Hara
Journal:  Jpn J Ophthalmol       Date:  2010-12-30       Impact factor: 2.447

Review 5.  The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.

Authors:  J K Dart
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

6.  Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease.

Authors:  Ujwala S Saboo; Francisco Amparo; Hasanain Shikari; Reza Dana
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-12       Impact factor: 3.117

7.  Dapsone therapy for the acute inflammatory phase of ocular pemphigoid.

Authors:  A I Fern; J L Jay; H Young; R MacKie
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

8.  Prostaglandin E2 and F2α Alter Expression of Select Cholesteryl Esters and Triacylglycerols Produced by Human Meibomian Gland Epithelial Cells.

Authors:  Jillian F Ziemanski; Landon Wilson; Stephen Barnes; Kelly K Nichols
Journal:  Cornea       Date:  2022-01-01       Impact factor: 3.152

Review 9.  [Mucous membrane pemphigoid with ocular involvement. Part II: therapy].

Authors:  T Meyer-ter-Vehn; E Schmidt; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

Review 10.  [Mucous membrane pemphigoid with ocular involvement. Part I: Clinical manifestations, pathogenesis and diagnosis].

Authors:  E Schmidt; T Meyer-Ter-Vehn; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.174

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.